BiotechTube
Home/Angios Biotech/Gregor Wick
GW

Gregor Wick

Chief Executive Officer

Angios Biotech

Therapeutic Areas

Diabetic VasculopathiesVascular Diseases

Angios Biotech Pipeline

DrugIndicationPhase
Diabetic Vasculopathy AntibodiesDiabetic VasculopathiesPre-clinical
Vascular TransplantsRegenerative Medicine / Vascular RepairPre-clinical
Blood Vessel Organoid PlatformDrug Screening ServicesPlatform Development

Leadership Team at Angios Biotech

TY
Teodor Yordanov
Chief Scientific Officer
FR
Florian Regensberger
Project Manager
TB
Tanila Ben Haddou
Scientist & Lab Manager
View full Angios Biotech profile